Clinton calls for lower price on allergy drug EpiPen

By Ginger Gibson WASHINGTON (Reuters) - Democratic presidential candidate Hillary Clinton called on pharmaceutical company Mylan NV to voluntarily drop the price of its severe allergy treatment drug EpiPen, which has increased in price by more than 400 percent in the past decade. "That's outrageous - and it's just the latest troubling example of a company taking advantage of its consumers," Clinton said in a statement. "It's wrong when drug companies put profits ahead of patients, raising prices without justifying the value behind them." Clinton frequently said during the primary that she would fight pharmaceutical companies - part of an attempt to counter criticism that she was too closely tied to the insurance industry.